Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study
Seok-Joo Chun, Nalee Kim, Do Hoon Lim, Joo-Young Kim, Chan Woo Wee, Hong In Yoon, Seung Hyuck Jeon, In Ah Kim, Joo Ho Lee · 2026
Read Impact of salvage treatment for recurrent medulloblastoma in previously irradiated patients (KROG 23-02): A multi-institutional retrospective study by Seok-Joo Chun, Nalee Kim, Do Hoon Lim, Joo-Young Kim, Chan Woo Wee, Hong In Yoon, Seung Hyuck Jeon, In Ah Kim, Joo Ho Lee (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13241757.txt.
Description
Seok-Joo Chun and co-authors present a 2026 multi-institutional Korean study of salvage treatment for medulloblastoma that returned after earlier radiation. This childhood brain tumor recurs in a sizable share of patients. Relapse care has no accepted standard and results are usually poor.
The authors reviewed outcomes across institutions for patients whose tumors came back after prior irradiation. Combined salvage approaches that layered several treatment types were linked to longer survival. Chemotherapy in particular tracked with slower disease progression and longer life. Modern repeat radiation appeared feasible with acceptable safety in this setting. The study gives clinicians comparative evidence for building salvage plans instead of defaulting to comfort care alone.
Catalog record
| CREATOR | Seok-Joo Chun, Nalee Kim, Do Hoon Lim, Joo-Young Kim, Chan Woo Wee, Hong In Yoon, Seung Hyuck Jeon, In Ah Kim, Joo Ho Lee |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |